Literature DB >> 12761102

Lipopolysaccharide-mimetic activities of a Toll-like receptor 2-stimulatory substance(s) in enterobacterial lipopolysaccharide preparations.

Masashi Muroi1, Takahiro Ohnishi, Satoko Azumi-Mayuzumi, Ken-ichi Tanamoto.   

Abstract

Lipopolysaccharide (LPS) preparations are known to often contain substances which activate cells through Toll-like receptor 2 (TLR2), and it is suspected that bacterial lipoproteins are responsible for this activation. We compared the mode of action of the TLR2-stimulatory substances with that of a synthetic bacterial lipopeptide (tripalmitoyl-Cys-Ser-Ser-Asn-Ala [Pam(3)CSSNA]), as well as with that of peptidoglycan. Six out of eight LPS preparations tested induced NF-kappaB-dependent reporter activity in 293 cells expressing CD14 and TLR2. Phenol extract (PEX) prepared from Escherichia coli LPS by modified phenol extraction induced reporter activity in 293 cells expressing TLR2, and this activity was enhanced by coexpression of CD14, whereas the activity of Pam(3)CSSNA was not dependent on CD14. The activity of PEX, but not that of Pam(3)CSSNA or peptidoglycan, was also enhanced by LPS binding protein or serum and blocked by polymyxin B. In addition, the activity of PEX was inhibited by a lipid A precursor (compound 406) in 293 cells expressing CD14 and TLR2. These results indicate that E. coli LPS preparations contain LPS-mimetic TLR2-stimulatory substances which differ from bacterial lipopeptides or peptidoglycan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761102      PMCID: PMC155748          DOI: 10.1128/IAI.71.6.3221-3226.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

4.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-kappaB through human toll-like receptor 4.

Authors:  Masashi Muroi; Ken-Ichi Tanamoto
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

7.  N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide.

Authors:  T Ohnishi; M Muroi; K Tanamoto
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

Review 8.  Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster.

Authors:  Martha Triantafilou; Kathy Triantafilou
Journal:  Trends Immunol       Date:  2002-06       Impact factor: 16.687

9.  Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B.

Authors:  Masashi Muroi; Takahiro Ohnishi; Ken-Ichi Tanamoto
Journal:  J Biol Chem       Date:  2002-08-23       Impact factor: 5.157

10.  MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A.

Authors:  Masashi Muroi; Takahiro Ohnishi; Ken-ichi Tanamoto
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  6 in total

1.  Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.

Authors:  Giuseppe Mancuso; Angelina Midiri; Carmelo Biondo; Concetta Beninati; Maria Gambuzza; Daniele Macrì; Antonella Bellantoni; Andrej Weintraub; Terje Espevik; Giuseppe Teti
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.

Authors:  Todd M Schaefer; Kristin Desouza; John V Fahey; Kenneth W Beagley; Charles R Wira
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

3.  Antiviral responses of human Fallopian tube epithelial cells to toll-like receptor 3 agonist poly(I:C).

Authors:  Mimi Ghosh; Todd M Schaefer; John V Fahey; Jacqueline A Wright; Charles R Wira
Journal:  Fertil Steril       Date:  2007-07-31       Impact factor: 7.329

4.  Fcγ receptors and toll-like receptor 9 synergize to drive immune complex-induced dendritic cell maturation.

Authors:  Nicole L J Nelson; Cheryl M Zajd; Michelle R Lennartz; Edmund J Gosselin
Journal:  Cell Immunol       Date:  2019-08-03       Impact factor: 4.868

5.  A human monocytic NF-κB fluorescent reporter cell line for detection of microbial contaminants in biological samples.

Authors:  Claire Battin; Annika Hennig; Patrick Mayrhofer; Renate Kunert; Gerhard J Zlabinger; Peter Steinberger; Wolfgang Paster
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

6.  Low-Dose Exposure to Ganglioside-Mimicking Bacteria Tolerizes Human Macrophages to Guillain-Barré Syndrome-Associated Antigens.

Authors:  Robert T Patry; Lauren Essler; Silke Andresen; Frederick D Quinn; Christine M Szymanski
Journal:  mBio       Date:  2022-02-01       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.